Modification of transplantability and tumor growth following treatment of L1210 leukemia and TA3Ha cells with macromomycin (NSC-170105).
D000230:Adenocarcinoma / Q000188:drug therapy*; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001426:Bacterial Proteins / Q000627:therapeutic use*; D002478:Cells, Cultured; D007939:Leukemia L1210 / Q000188:drug therapy*; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy*; D051379:Mice; D008811:Mice, Inbred DBA; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D014184:Transplantation, Homologous
D000903:Antibiotics, Antineoplastic; D001426:Bacterial Proteins